… Author contributions: Daniela-Elena Oprea-Lager had full access to all the data in the study
and takes responsibility for the integrity of the data and the accuracy of the data analysis. …

Response evaluation criteria in solid tumours (RECIST) v1.1 are currently the reference
standard for evaluating efficacy of therapies in patients with solid tumours who are included in …

Breast cancer remains the most common cause of cancer death among women. Despite its
considerable histological and molecular heterogeneity, those characteristics are not …

After three years of COVID-pandemic, and in that setting an once postponed and eventually
cancelled European Association of Nuclear medicine (EANM) Focus 4 on molecular …

Purpose Primary objective was to compare the per-patient detection rates (DR) of [ 18 F]DCFPyL
versus [ 18 F]fluoromethylcholine positron emission tomography/computed tomography …

TPS5113 Background: Previous randomized clinical trials have shown an improvement in
overall survival in patients with metastatic castration resistant prostate cancer (mCRPC), who …

Ever since the first captivating X-ray images of Mrs. Roentgen’s left hand, medical imaging
has been at the heart of clinical decision-making. Over a century later, the explosion in …

Choline-based PET has proven value in several neoplasms, and especially in prostate cancer
(PC)[1, 2].[18F] FCH PET/CT seems to become a useful imaging tool to solve the clinical …

Purpose Primary objective was to compare the per-patient detection rates (DR) of [18F] DCFPyL
versus [18F] fluoromethylcholine positron emission tomography/computed tomography (…

Response evaluation criteria in solid tumours (RECIST) v1. 1 are currently the reference
standard for evaluating efficacy of therapies in patients with solid tumours who are included in …